Trials / Withdrawn
WithdrawnNCT01339949
Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV)
A Double-masked, Sham Controlled, Study to Evaluate the Safety and Effectiveness of Low Voltage Stereotactic Radiosurgery in Wet AMD Patients With Recurrent Leakage Secondary to CNV
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Oraya Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to confirm the safety and to establish the effectiveness of low voltage external beam radiosurgery using the IRay System for the treatment of subjects with recurrent leakage secondary to neovascular Age-related Macular Degeneration (AMD) as determined by decreasing the number of Lucentis injections required during the first 12 months of the study.
Detailed description
The objective of this study is to confirm the safety and to establish the effectiveness of low voltage external beam radiosurgery using the IRay System for the treatment of subjects with recurrent leakage secondary to neovascular AMD as determined by decreasing the number of Lucentis injections required during the first 12 months of the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | IRay | low voltage external beam radiosurgery |
| DEVICE | IRay | low voltage external beam radiosurgery |
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2012-10-01
- Completion
- 2014-10-01
- First posted
- 2011-04-21
- Last updated
- 2011-12-30
Locations
3 sites across 2 countries: Italy, United Kingdom
Source: ClinicalTrials.gov record NCT01339949. Inclusion in this directory is not an endorsement.